Nvidia - Weight Loss Drug - Meridian

Devon Funds Head of Retail Greg Smith talks to ZB’s Mike Hosking about recent volatility in AI darling Nvidia and whether it is a blip or the end of a bubble. He also discusses the investor party over-weight loss drugs in the US and Europe. Back home he looks at the good news flowing from Meridian’s Investor day with more solar and wind on its way at a cheaper price. For more market insights and our terms and conditions, visit www.devonfunds.co.nz